News from canntab therapeutics limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 22, 2022, 07:14 ET CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET

TORONTO, Aug. 22, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading...

Aug 02, 2022, 13:05 ET CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO

TORONTO, Aug. 2, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN)(OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Jun 30, 2022, 16:30 ET Canntab Corporate Update

TORONTO, June 30, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading...

May 30, 2022, 16:05 ET CANNTAB ANNOUNCES CHANGE OF AUDITOR

TORONTO, May 30, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading...

Apr 13, 2022, 07:11 ET Canntab Engages Hamish Sutherland as Strategic Advisor

TORONTO, April 13, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading...

Mar 23, 2022, 07:49 ET CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED

Signs Affiliate Program with OnPharm-United with over 600 pharmacies in Ontario Receives approval from the Province of Saskatchewan to begin sales...

Feb 07, 2022, 07:21 ET CANNTAB SIGNS HISTORIC AGREEMENT WITH FIRST NATIONS GROWERS GP INC. TO ADDRESS THE OPIATE AND ILLICIT DRUG CRISIS AFFECTING INDIGENOUS PEOPLES THROUGHOUT CANADA

TORONTO, Feb. 7, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1) (the "Company" or "Canntab"), a leading...

Feb 01, 2022, 22:58 ET CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE

Canntab Therapeutics Limited ("Canntab" or the "Company") (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the leading innovator in cannabinoid and terpene...

Jan 20, 2022, 06:30 ET CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM

TORONTO, Jan. 20, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading...

Jan 10, 2022, 06:30 ET CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

TORONTO, Jan. 10, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading...

Dec 16, 2021, 06:30 ET CANNTAB ENTERS INTO STRATEGIC PARTNERSHIP TO PROVIDE ALTERNATIVES TO OPIATES THROUGH LEVITEE CLINICS

Agreement with Levitee to service over 35,000 annual patient visits with the aim to help treat their patients with substance use addictions and...

Nov 11, 2021, 08:49 ET Canntab Receives Medical Sales Licence from Health Canada

TORONTO, Nov. 11, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Oct 18, 2021, 07:30 ET Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.

TORONTO, Oct. 18, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Jun 03, 2021, 07:34 ET Canntab Announces the Early Exercise of $1,259,250 Warrants

TORONTO, June 3, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Mar 30, 2021, 07:30 ET Canntab Receives Export License Approval from Health Canada

TORONTO, March 30, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a...

Mar 09, 2021, 00:05 ET Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia

3rd Patent Grant with Australia following the United States and Canada Initial Australian Purchase Order of $406,200 from our Australian partner Cann ...

Feb 01, 2021, 09:27 ET Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets

TORONTO, Feb. 1, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading ...

Dec 01, 2020, 08:30 ET Canntab Begins Delivery of Tablets to MediPharm

TORONTO, Dec. 1, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Oct 26, 2020, 00:53 ET Canntab to Launch in Australia and Participate in Australia's Largest Cannabis Research Study

TORONTO, Oct. 26, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Sep 21, 2020, 09:14 ET Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets

TORONTO, Sept. 21, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Aug 21, 2020, 08:56 ET Canntab announces planned purchases of cannabis processing equipment and leasehold improvements

TORONTO, Aug. 21, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Aug 19, 2020, 07:30 ET Canntab Appoints Larry Latowsky as CEO

TORONTO, Aug. 19, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Jun 02, 2020, 10:41 ET Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement

TORONTO, June 2, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

May 15, 2020, 07:30 ET Canntab Appoints Joshi Laxminarayan as Chief Scientific Officer

TORONTO, May 15, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

May 11, 2020, 07:30 ET Canntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference

TORONTO, May 11, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...